Natural Killer Cell Therapy in Children with Relapsed Leukemia

BACKGROUND: Novel therapies are needed for children with relapsed or refractory leukemia. We therefore tested the safety and feasibility of haploidentical natural killer cell therapy in this patient population. PROCEDURE: Twenty-nine children who had relapsed or refractory leukemia were treated with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pediatr Blood Cancer
Auteurs principaux: Rubnitz, Jeffrey E., Inaba, Hiroto, Kang, Guolian, Gan, Kwan, Hartford, Christine, Triplett, Brandon M., Dallas, Mari, Shook, David, Gruber, Tanja, Pui, Ching-Hon, Leung, Wing
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634362/
https://ncbi.nlm.nih.gov/pubmed/25925135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25555
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires